It’s relatively simple to go online and get a prescription for a GLP-1 medication for diabetes or obesity thanks to dozens of companies that have stepped in to fill demand for the potentially ...

It may be too late for Viking to take on the "dark horse" role in the GLP-1 wars.

As food becomes less stimulating, GLP-1 users are gravitating toward this pricey obsession.

The number of weight-loss surgery procedures in the United States is dropping rapidly in the face of cutting-edge drugs like Ozempic and Zepbound, a new study says. These procedures dropped by more ...

Eli Lilly (NYSE: LLY) has become a beast in healthcare. The excitement surrounding its GLP-1 drugs, Mounjaro and Zepbound, has helped boost its market capitalization to around $650 billion. Over the ...

Big shifts GLP-1 market include FDA approval of oral weight loss drugs and expanded Medicare coverage starting July 2024 for key GLP-1 therapies.

Side effects like nausea, vomiting, diarrhea and constipation are common soon after starting GLP-1s or increasing the drug’s dosage. A nutrient-dense diet and regular exercise a ...